Welcome to Heart Matters – Empowering Heart Health
Conditions

First-Degree AV Block on Your ECG: What Does It Really Mean?

First degree AV block is a common ECG finding that can sound alarming but is often harmless. In most cases, it simply means the electrical signal in your heart is moving a little more slowly than usual. This article explains what it means, what causes it, and when, if ever, it requires further attention.

No doubt it can be worrying to see the words “first-degree AV block” on your ECG report, especially if you’re otherwise healthy and had no symptoms when the test was done. Understandably, many people fear that anything with the word “block” must be serious or dangerous. But in the case of first-degree AV block, this is usually not the case.

In this article, we will explain what first-degree AV block means in plain terms, why it shows up on ECGs, what causes it, when it might matter, and when it’s simply a benign finding that doesn’t need treatment.

 

What Is First-Degree AV Block?

Your heart has an electrical system that controls how it beats. This system ensures that each heartbeat starts in the top chambers (the atria), travels through a small delay point known as the atrioventricular (AV) node, and then continues to the bottom chambers (the ventricles) so they contract in a coordinated way.

In first-degree AV block, the electrical signal still gets through but it takes a little longer than usual. On an ECG, this is seen as a prolonged PR interval (greater than 200 milliseconds, or 0.2 seconds). In practical terms, the heart rhythm is still regular, and every signal from the atria reaches the ventricles. It’s not a “block” in the true sense of the word, but more of a delay.

 

What Causes It?

There are many reasons why a person might have a prolonged PR interval, and in many cases, it’s not a sign of disease. Some of the more common causes include:

  • Normal variation: In healthy individuals, especially younger people or athletes, a slightly prolonged PR interval may simply reflect a more “relaxed” conduction system.
  • Medications: Certain drugs that affect the heart’s electrical signals such as beta blockers, calcium channel blockers, digoxin, or antiarrhythmic medications, can prolong the PR interval.
  • Vagal tone: Increased activity of the vagus nerve, which slows down heart rate and conduction, can lead to a longer PR interval. This is often seen in people who are very fit or have strong resting parasympathetic tone.
  • Age-related changes: As we age, the conduction system may undergo mild fibrotic changes, which can prolong signal conduction without causing symptoms.
  • Underlying heart disease: In some cases, especially if there are other ECG changes or symptoms, a prolonged PR interval may be part of a broader issue like ischemic heart disease, myocarditis, or infiltrative conditions affecting the heart.

In most cases, first-degree AV block is harmless and doesn’t progress.

When Is It a Concern?

In most cases, first-degree AV block is harmless and doesn’t progress. Many people live with it for years without needing any treatment or even knowing they have it.

However, there are some situations where further evaluation may be helpful:

  • Symptoms: If the person has symptoms like dizziness, fatigue, or fainting, we would look more closely to see if the delay is part of a more complex conduction issue.
  • Very long PR interval: When the PR interval becomes significantly prolonged (greater than 300 milliseconds), it can sometimes lead to inefficient heartbeats or a condition called “pseudo-pacemaker syndrome.”
  • Associated abnormalities: If the ECG also shows other conduction delays like bundle branch blocks or signs of second- or third-degree AV block it may require further cardiac testing.
  • Family history: Rarely, conduction disease can be part of inherited electrical disorders. A detailed family and personal history can help identify if genetic testing or electrophysiological evaluation is needed.

 

What Tests Might Be Done?

If there’s any uncertainty about the significance of the first-degree AV block, your doctor might recommend:

  • A repeat ECG: to see if the PR interval changes over time.
  • Holter monitor: a 24-hour ECG to assess for any intermittent conduction issues or abnormal rhythms.
  • Echocardiogram: to check the structure and function of the heart.
  • Exercise stress test: to see how the conduction system behaves under physical demand, especially if symptoms are brought on with activity.

 

Is Treatment Needed?

Most people with first-degree AV block do not need any treatment at all. It’s generally considered a benign finding, especially in healthy, asymptomatic individuals. If the delay is medication-related, sometimes the drug dose can be adjusted if necessary. In very rare cases of extremely prolonged PR intervals with symptoms, a pacemaker may be considered, but this is uncommon.

 

Conclusion

Seeing “first-degree AV block” on your ECG report can understandably raise questions but in the majority of cases, it’s not a cause for concern. It simply means the electrical signal from the top to bottom chambers of your heart is moving a little more slowly than usual, but still effectively.

If you’re not experiencing symptoms and your heart structure is normal, there’s usually no need for intervention. Still, it’s always worth discussing your results with your doctor, especially if you’ve had changes in your ECG or are taking heart medications. For more information about ECG findings and what they mean, visit our Heart Glossary or explore our related articles at Heart Matters.

About the author
Cardiologist & Founding Editor

Peter is an interventional cardiologist and the Founding Editor of Heart Matters, a trusted resource for heart health education. With more than 20 years of clinical experience, he is dedicated to making cardiovascular care more understandable and accessible. His work bridges patient care, research, and public education, empowering individuals to take control of their heart health. Professor Barlis is internationally recognised for his contributions to cardiology, with numerous publications and speaking engagements around the world.

Our Youtube Channel

Discover our Heart Matters YouTube channel, where we bring heart health to life. From explaining common conditions and symptoms to discussing the latest research, our engaging videos simplify complex topics, ensuring you have access to valuable knowledge for a healthier heart. Subscribe now and embark on a journey of education, empowerment, and inspiration.

Editor's Picks

Subscribe to our newsletter and be the first to receive valuable insights, tips, and resources on heart health.

other anti-anginals

When first-line therapies for angina, such as beta blockers, calcium channel blockers, and nitrates, prove inadequate or are not well-tolerated, second-line therapies may be considered.
Perhexiline is a unique medication that enhances the heart's ability to utilize fatty acids for energy, reducing its reliance on oxygen and lowering oxygen demand. This action helps improve blood flow and alleviates chest pain in some patients with refractory angina.
Nicorandil is another second-line option with a dual mechanism of action. It opens potassium channels in smooth muscle cells, causing vasodilation and enhancing coronary blood flow. Additionally, nicorandil also stimulates nitric oxide release, further dilating blood vessels and reducing heart workload.
Trimetazidine is an anti-ischemic agent that improves cardiac efficiency by enhancing glucose metabolism and shifting the heart's energy production to a more oxygen-efficient process. As second-line therapies, these medications offer alternative approaches for managing angina in individuals who do not respond adequately to first-line treatments or those experiencing side effects from other medications.

lipid lowering therapies

Lipid-lowering therapies are essential in managing coronary artery disease (CAD), a condition where the arteries supplying blood to the heart become narrowed. Among the most commonly prescribed treatments are statins, which reduce cholesterol production in the liver and significantly lower the risk of heart attacks and strokes.

Other medications may be used to target different aspects of lipid metabolism:

  • Ezetimibe helps reduce the absorption of cholesterol in the gut
  • Fibrates lower triglyceride levels
  • Niacin can help raise high-density lipoprotein (HDL) cholesterol

In recent years, a newer class of medications known as PCSK9 inhibitors—such as Repatha (evolocumab)—has become available. These drugs block a specific enzyme involved in cholesterol regulation and can dramatically lower LDL cholesterol, particularly in patients who do not achieve target levels with statins alone.

Together, these therapies provide a range of options to personalise treatment and improve cardiovascular outcomes.

Nitrates

Nitrates for Angina Relief

Nitrates are widely used to treat angina and provide quick relief from chest pain. These medications are commonly available as sublingual sprays or tablets, skin patches, and long-acting tablets.

Nitrates work by dilating blood vessels, allowing for increased blood flow and reduced vascular resistance. This reduces the heart’s workload and lowers its oxygen demand, offering prompt relief from angina symptoms.

Sublingual nitrates act quickly and are typically used at the onset of angina symptoms, while patches and long-acting tablets are used for ongoing prevention.

Common side effects include headaches, dizziness, and flushing. These often improve with continued use but should be discussed with a healthcare provider if persistent or bothersome.

calcium channel blockers

Calcium channel blockers, including amlodipine, felodipine, Cardizem (diltiazem), and verapamil, are commonly prescribed for the treatment of angina.

These medications work by inhibiting the influx of calcium into the muscle cells of the heart and blood vessels, causing them to relax. This relaxation leads to the widening of blood vessels, which improves blood flow and reduces blood pressure.

For individuals with angina, calcium channel blockers reduce the heart’s workload and oxygen demand, helping to relieve chest pain and prevent angina episodes.

While effective, they may cause side effects such as headaches, dizziness, facial flushing, and ankle swelling. These effects should be monitored and discussed with your healthcare provider if they persist.

Beta blockers

Beta blockers, such as metoprolol, propranolol, atenolol, carvedilol, and bisoprolol, play a crucial role in managing angina.

These medications work by blocking specific receptors in the heart, which slows the heart rate and reduces the strength of each contraction. This results in a lower oxygen demand by the heart and helps relieve chest pain associated with angina.

Beta blockers are highly effective in both relieving symptoms and preventing angina episodes. However, they may cause side effects in some individuals, including tiredness, worsened asthma symptoms, more vivid dreams, and erectile dysfunction in some males.

It is important to consult your healthcare provider to determine whether beta blockers are a suitable option for your angina and overall heart health.

Anti-platelet Medications

Anti-platelet medications play a crucial role in preventing blood clot formation and reducing the risk of serious cardiovascular events such as heart attacks and strokes. Commonly used agents include aspirin, clopidogrel, and ticagrelor.

 

Aspirin: This well-known medication inhibits platelet activation, reducing the likelihood that platelets will clump together and form clots. It is widely used for both primary and secondary prevention of heart attacks and strokes.

 

Clopidogrel: A potent anti-platelet agent, clopidogrel works by blocking specific receptors on platelets to prevent aggregation. It is commonly prescribed for patients with acute coronary syndrome, those undergoing stent placement, and some individuals with peripheral arterial disease.

 

Ticagrelor: Ticagrelor also inhibits platelet activation and is typically used in the treatment of acute coronary syndrome. It is often prescribed alongside aspirin to provide dual anti-platelet therapy and further reduce the risk of heart-related events.